Pharmaron Beijing Sets Out Board and Committee Structure for Third Board Session
I'm PortAI, I can summarize articles.
Pharmaron Beijing Co., Ltd. has announced the composition of its board of directors and the structure of its four key board committees: Audit, Remuneration and Appraisal, Nomination, and Strategy. This move aims to enhance corporate governance and transparency. The company operates in the pharmaceutical and life sciences sector, providing research and development services. The latest analyst rating for its stock (HK:3759) is a Buy with a target price of HK$28.10.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments